nivolumab
bms
['urothelial', 'check,mate,274', 'nivo']
 great time with galsky, md showing us results from the checkmate 274 trial that continued to show dfs, nutrfs, and dmfs benefits versus pbo.these results further support adjuvant nivo as a standard of care for high-risk miuc after radical resection. #ascogu2023 
Medical Oncologist at Centro Oncológico Integral, Hospital Ángeles Puebla. Cancer treatment must be personalized to the individual needs of the patient.